Search

everythinglearnresearchcommunity

for

Search:↓

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

A boy's hair, nails, and skin improved after 6 months of steroid treatment.

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

A man had an allergic reaction to minoxidil, which stopped after he discontinued use and started corticosteroids.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Satoyoshi syndrome can occur without causing premature ovarian failure.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

This therapy effectively treats resistant alopecia areata with minimal side effects.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

The document concludes that hair loss in cats is caused by various factors, including allergies, mites, infections, and hormonal issues, with treatments varying accordingly.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.